Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Denis Campbell Health policy editor

UK shortage of critical drug forcing pancreatic cancer patients to skip meals

Creon, a form of pancreatic enzyme replacement therapy (PERT), helps people with pancreatic cancer to digest food.
Creon, a form of pancreatic enzyme replacement therapy (PERT), helps people with pancreatic cancer to digest food. Photograph: Davidi Vardi/Shutterstock

People with pancreatic cancer are eating only one meal a day because of an acute shortage of a drug that helps them digest their food.

Patients with cystic fibrosis and pancreatitis are also affected by the widespread scarcity of Creon, a form of pancreatic enzyme replacement therapy (PERT).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.